(Q36343776)

13 August 2017

1 reference

title

Swedish guidelines for the management of community-acquired pneumonia in immunocompetent adults (English)

1 reference

13 August 2017

0 references

0 references

2

Kristoffer Strålin

1 reference

13 August 2017

Jonas Hedlund

1

1 reference

13 August 2017

Ake Ortqvist

series ordinal

3

1 reference

13 August 2017

Hans Holmberg

series ordinal

4

1 reference

13 August 2017

Community-Acquired Pneumonia Working Group of the Swedish Society of Infectious Diseases

series ordinal

5

1 reference

13 August 2017

publication date

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

37

1 reference

13 August 2017

issue

11-12

1 reference

13 August 2017

page(s)

791-805

1 reference

The cost of treating community-acquired pneumonia.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

2004 update of BTS pneumonia guidelines: what's new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Prospective study of the aetiology and outcome of pneumonia in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Rates of pneumonia during influenza epidemics in Seattle, 1964 to 1975.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Community-acquired pneumonia: the annual cost to the National Health Service in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Management of patients with community-acquired pneumonia treated in hospital in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Limited value of routine microbiological diagnostics in patients hospitalized for community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Aetiology of community-acquired pneumonia in hospital treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Factors of importance for the long term prognosis after hospital treated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Pneumonia: still the old man's friend?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Infections with viruses in patients hospitalized with acute respiratory illness, Stockholm 1963-1967.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Etiology of community-acquired pneumonia in patients requiring hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Rapid aetiological diagnosis of pneumonia based on routine laboratory features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Regional differences of Chlamydia pneumoniae as causative agent of pneumonia in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Rapid diagnosis of respiratory Chlamydia pneumoniae infection by nested touchdown polymerase chain reaction compared with culture and antigen detection by EIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Pneumonia: a deadly disease despite intensive care treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Comparative radiographic features of community acquired Legionnaires' disease, pneumococcal pneumonia, mycoplasma pneumonia, and psittacosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Comparative Features of Pneumococcal, Mycoplasmal, and Legionnaires' Disease Pneumonias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Legionella species community-acquired pneumonia. A review of 56 hospitalized adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Clinical study of an outbreak of Legionnaire's disease in Alcoy, Southeastern Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Community acquired pneumonia: aetiology and usefulness of severity criteria on admission

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Recurrence of pneumonia in middle-aged and elderly adults after hospital-treated pneumonia: aetiology and predisposing conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

A hospital study of community acquired pneumonia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Comparison of a disease-specific and a generic severity of illness measure for patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Severe community-acquired pneumonia. Etiology, prognosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

A prediction rule to identify low-risk patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Predicting death in patients hospitalized for community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Prospective study of epidemiology and prognostic factors in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Severe Community-acquired Pneumonia: Epidemiology and Prognostic Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Community-acquired pneumonia of diverse aetiology: prognostic features in patients admitted to an intensive care unit and a "severity of illness" core.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Severe community-acquired pneumonia. Assessment of severity criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Quality of care, process, and outcomes in elderly patients with pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Comparison of two urinary antigen tests for establishment of pneumococcal etiology of adult community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

A 3-year prospective study of a urinary antigen-detection test for Streptococcus pneumoniae in community-acquired pneumonia: utility and clinical impact on the reported etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Mycoplasma pneumoniae and its role as a human pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Laboratory diagnosis of Mycoplasma pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Molecular genetic methods in the diagnosis of lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Development of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae in respiratory tract secretions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Design of a multiplex PCR for Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae and Chlamydophila pneumoniae to be used on sputum samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

The pneumoplex assays, a multiplex PCR-enzyme hybridization assay that allows simultaneous detection of five organisms, Mycoplasma pneumoniae, Chlamydia (Chlamydophila) pneumoniae, Legionella pneumophila, Legionella micdadei, and Bordetella pertussi

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Legionella urinary antigen testing: potential impact on diagnosis and antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Evaluation of a direct immunofluorescence assay, dot-blot enzyme immunoassay, and shell vial culture in the diagnosis of lower respiratory tract infections caused by influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Comparison of the directigen flu A+B membrane enzyme immunoassay with viral culture for rapid detection of influenza A and B viruses in respiratory specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Comparison of a new lateral-flow chromatographic membrane immunoassay to viral culture for rapid detection and differentiation of influenza A and B viruses in respiratory specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

The role of bronchoalveolar lavage in diagnosing nonopportunistic bacterial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Impact of BAL in the management of pneumonia with treatment failure: positivity of BAL culture under antibiotic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

How contagious are common respiratory tract infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Oral administration of antibiotics: a rational alternative to the parenteral route

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Current practice in penicillin dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Antibiotic treatment of community-acquired pneumonia in clinical practice: a European perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Antibiotic therapy in pneumonia: a comparative study of parenteral and oral administration of penicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

A European study on the relationship between antimicrobial use and antimicrobial resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Short-course beta-lactam treatment for community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Role of beta-lactam agents in the treatment of community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Sequential switch therapy for lower respiratory tract infections: a European perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Instability on hospital discharge and the risk of adverse outcomes in patients with pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Bottle-blowing in hospital-treated patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Nonresolving pneumonia and mimics of pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Measuring symptomatic and functional recovery in patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Additive preventive effect of influenza and pneumococcal vaccines in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Effectiveness of pneumococcal polysaccharide vaccine in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Community-acquired pneumonia requiring hospitalization: 5-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Combination Antibiotic Therapy Lowers Mortality among Severely Ill Patients with Pneumococcal Bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Simplified Prediction Rule for Prognosis of Patients With Severe Community-Acquired Pneumonia in ICUs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Effect of Clonal and Serotype‐Specific Properties on the Invasive Capacity ofStreptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Risk Factors for Acquiring Pneumococcal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

Detection of Streptococcus pneumoniae Antigen by a Rapid Immunochromatographic Assay in Urine Samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540500264050

10.1080/00365540500264050

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference